These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16687991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation.
    Koran LM, Chuong HW, Bullock KD, Smith SC.
    J Clin Psychiatry; 2003 Jul; 64(7):793-8. PubMed ID: 12934980
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 4. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
    Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.
    CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
    [Abstract] [Full Text] [Related]

  • 5. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase.
    Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E.
    J Clin Psychiatry; 2008 Mar; 69(3):452-6. PubMed ID: 18312057
    [Abstract] [Full Text] [Related]

  • 6. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
    Davidson JR, Bose A, Korotzer A, Zheng H.
    Depress Anxiety; 2004 Mar; 19(4):234-40. PubMed ID: 15274172
    [Abstract] [Full Text] [Related]

  • 7. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ, Gergel I, Bose A.
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [Abstract] [Full Text] [Related]

  • 8. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [Abstract] [Full Text] [Related]

  • 9. An open-label trial of escitalopram in the treatment of pathological gambling.
    Black DW, Shaw M, Forbush KT, Allen J.
    Clin Neuropharmacol; 2007 May; 30(4):206-12. PubMed ID: 17762317
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.
    Davidson JR, Bose A, Wang Q.
    J Clin Psychiatry; 2005 Nov; 66(11):1441-6. PubMed ID: 16420082
    [Abstract] [Full Text] [Related]

  • 11. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R.
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [Abstract] [Full Text] [Related]

  • 12. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM, Gergel I, Li D.
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [Abstract] [Full Text] [Related]

  • 13. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
    Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M.
    J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
    [Abstract] [Full Text] [Related]

  • 14. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
    Grant JE, Kim SW, Odlaug BL.
    Biol Psychiatry; 2007 Sep 15; 62(6):652-7. PubMed ID: 17445781
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
    Grant JE, Kim SW, Hartman BK.
    J Clin Psychiatry; 2008 May 15; 69(5):783-9. PubMed ID: 18384246
    [Abstract] [Full Text] [Related]

  • 16. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J, Goa KL.
    CNS Drugs; 2003 May 15; 17(5):343-62. PubMed ID: 12665392
    [Abstract] [Full Text] [Related]

  • 17. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
    Montgomery SA, Nil R, Dürr-Pal N, Loft H, Boulenger JP.
    J Clin Psychiatry; 2005 Oct 15; 66(10):1270-8. PubMed ID: 16259540
    [Abstract] [Full Text] [Related]

  • 18. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S, Osatuke K, Aslam M, Kasckow J.
    Am J Geriatr Pharmacother; 2006 Sep 15; 4(3):201-9. PubMed ID: 17062320
    [Abstract] [Full Text] [Related]

  • 19. Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study.
    Strawn JR, Mills JA, Schroeder H, Mossman SA, Varney ST, Ramsey LB, Poweleit EA, Desta Z, Cecil K, DelBello MP.
    J Clin Psychiatry; 2020 Aug 25; 81(5):. PubMed ID: 32857933
    [Abstract] [Full Text] [Related]

  • 20. Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.
    Koran LM, Aboujaoude EN, Gamel NN.
    J Clin Psychiatry; 2007 Mar 25; 68(3):422-7. PubMed ID: 17388713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.